Precipio Inc (PRPO) - Net Assets

Latest as of September 2025: $13.75 Million USD

Based on the latest financial reports, Precipio Inc (PRPO) has net assets worth $13.75 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($21.15 Million) and total liabilities ($7.40 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check PRPO asset liquidity ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric Value
Current Net Assets $13.75 Million
% of Total Assets 65.0%
Annual Growth Rate N/A
5-Year Change -14.6%
10-Year Change N/A
Growth Volatility 74.88

Precipio Inc - Net Assets Trend (1999–2024)

This chart illustrates how Precipio Inc's net assets have evolved over time, based on quarterly financial data. Also explore how large is Precipio Inc's balance sheet for the complete picture of this company's asset base.

Annual Net Assets for Precipio Inc (1999–2024)

The table below shows the annual net assets of Precipio Inc from 1999 to 2024. For live valuation and market cap data, see PRPO market cap overview.

Year Net Assets Change
2024-12-31 $12.09 Million -16.18%
2023-12-31 $14.43 Million -11.84%
2022-12-31 $16.37 Million -33.48%
2021-12-31 $24.60 Million +73.73%
2020-12-31 $14.16 Million +7.25%
2019-12-31 $13.21 Million +115.66%
2018-12-31 $6.12 Million -52.99%
2017-12-31 $13.03 Million +167.31%
2016-12-31 $-19.35 Million -50.94%
2015-12-31 $-12.82 Million -295.64%
2014-12-31 $6.55 Million -42.75%
2013-12-31 $11.45 Million -43.54%
2012-12-31 $20.27 Million +83.51%
2011-12-31 $11.05 Million +29.98%
2010-12-31 $8.50 Million -27.11%
2009-12-31 $11.66 Million -11.68%
2008-12-31 $13.21 Million -6.36%
2007-12-31 $14.10 Million -12.07%
2006-12-31 $16.04 Million -10.43%
2005-12-31 $17.91 Million +8.29%
2004-12-31 $16.54 Million -63.30%
2003-12-31 $45.06 Million -26.75%
2002-12-31 $61.51 Million -25.08%
2001-12-31 $82.10 Million +11.00%
2000-12-31 $73.97 Million +3623.10%
1999-12-31 $-2.10 Million --

Equity Component Analysis

This analysis shows how different components contribute to Precipio Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 9009592500.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $15.00K 0.12%
Other Components $114.52 Million 946.91%
Total Equity $12.09 Million 100.00%

Precipio Inc Competitors by Market Cap

The table below lists competitors of Precipio Inc ranked by their market capitalization.

Company Market Cap
nTels Co. Ltd
KQ:069410
$31.62 Million
Rotork PLC
LSE:ROR
$31.62 Million
Dayou A-Tech
KO:002880
$31.63 Million
Advance NanoTek Limited
F:BBJ
$31.64 Million
Chin Yang Chem
KO:051630
$31.61 Million
Bitcoin Depot Inc.
NASDAQ:BTM
$31.61 Million
Kuk Young G&M Co. Ltd
KQ:006050
$31.58 Million
Brand Concepts Limited
NSE:BCONCEPTS
$31.58 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Precipio Inc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 14,429,000 to 12,094,000, a change of -2,335,000 (-16.2%).
  • Net loss of 4,290,000 reduced equity.
  • New share issuances of 78,000 increased equity.
  • Other factors increased equity by 1,877,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-4.29 Million -35.47%
Share Issuances $78.00K +0.64%
Other Changes $1.88 Million +15.52%
Total Change $- -16.18%

Book Value vs Market Value Analysis

This analysis compares Precipio Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 3.75x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1999-12-31 $-872.23 $30.94 x
2000-12-31 $24022.73 $30.94 x
2001-12-31 $19656.21 $30.94 x
2002-12-31 $14086.10 $30.94 x
2003-12-31 $9937.80 $30.94 x
2004-12-31 $61564.52 $30.94 x
2005-12-31 $54188.35 $30.94 x
2006-12-31 $35213.53 $30.94 x
2007-12-31 $30962.10 $30.94 x
2008-12-31 $28992.67 $30.94 x
2009-12-31 $25604.88 $30.94 x
2010-12-31 $18641.99 $30.94 x
2011-12-31 $24172.41 $30.94 x
2012-12-31 $31542.59 $30.94 x
2013-12-31 $708.86 $30.94 x
2014-12-31 $393.53 $30.94 x
2015-12-31 $-9364.50 $30.94 x
2016-12-31 $-403125.00 $30.94 x
2017-12-31 $842.28 $30.94 x
2018-12-31 $84.98 $30.94 x
2019-12-31 $46.37 $30.94 x
2020-12-31 $17.16 $30.94 x
2021-12-31 $23.29 $30.94 x
2022-12-31 $14.33 $30.94 x
2023-12-31 $11.12 $30.94 x
2024-12-31 $8.25 $30.94 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Precipio Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -35.47%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -26.87%
  • • Asset Turnover: 0.94x
  • • Equity Multiplier: 1.41x
  • Recent ROE (-35.47%) is above the historical average (-67.30%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1999 0.00% -42.66% 1.15x 0.00x $-9.62 Million
2000 -11.71% -33.46% 0.33x 1.05x $-16.06 Million
2001 -9.01% -19.24% 0.43x 1.09x $-15.61 Million
2002 -34.73% -56.89% 0.51x 1.20x $-27.52 Million
2003 -50.95% -67.79% 0.59x 1.27x $-27.46 Million
2004 -207.87% -101.73% 0.90x 2.27x $-36.03 Million
2005 -83.73% -58.05% 1.02x 1.42x $-16.78 Million
2006 -21.39% -14.65% 1.10x 1.33x $-5.03 Million
2007 -14.94% -9.09% 1.21x 1.35x $-3.52 Million
2008 -3.75% -2.06% 1.37x 1.33x $-1.82 Million
2009 -16.46% -8.72% 1.38x 1.37x $-3.09 Million
2010 -36.87% -15.63% 0.63x 3.77x $-3.98 Million
2011 -88.54% -30.60% 0.95x 3.04x $-10.89 Million
2012 -41.07% -26.45% 0.81x 1.91x $-10.35 Million
2013 -139.67% -58.04% 0.91x 2.65x $-17.13 Million
2014 -212.76% -51.48% 0.90x 4.58x $-14.60 Million
2015 0.00% -1993.59% 0.34x 0.00x $-31.67 Million
2016 0.00% -489.15% 1.24x 0.00x $-5.68 Million
2017 -158.88% -1201.04% 0.06x 2.09x $-22.00 Million
2018 -256.31% -547.97% 0.13x 3.53x $-16.31 Million
2019 -100.29% -423.50% 0.16x 1.48x $-14.56 Million
2020 -75.17% -174.41% 0.29x 1.47x $-12.04 Million
2021 -34.81% -96.62% 0.29x 1.24x $-11.01 Million
2022 -74.86% -129.65% 0.44x 1.32x $-13.83 Million
2023 -40.56% -38.51% 0.84x 1.25x $-7.30 Million
2024 -35.47% -26.87% 0.94x 1.41x $-5.50 Million

Industry Comparison

This section compares Precipio Inc's net assets metrics with peer companies in the Diagnostics & Research industry.

Industry Context

  • Industry: Diagnostics & Research
  • Average net assets among peers: $543,908,184
  • Average return on equity (ROE) among peers: -221.59%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Precipio Inc (PRPO) $13.75 Million 0.00% 0.54x $31.61 Million
Agilent Technologies Inc (A) $2.51 Billion -1.24% 2.04x $32.42 Billion
Advanced Biomed Inc. Common Stock (ADVB) $3.49 Million -115.35% 0.92x $7.19 Million
Applied DNA Sciences Inc (APDN) $11.11 Million -144.24% 0.30x $3.99 Million
Biodesix Inc (BDSX) $4.58 Million -1138.56% 20.64x $79.44 Million
bioAffinity Technologies, Inc. (BIAF) $7.28 Million -204.87% 0.51x $9.85 Million
Biocept Inc. (BIOCQ) $11.20 Million -224.43% 0.58x $262.00
BillionToOne, Inc. Class A Common Stock (BLLN) $30.47 Million -271.32% 5.29x $3.21 Billion
Burning Rock Biotech Ltd (BNR) $2.42 Billion -16.82% 0.10x $154.44 Million
CareDx Inc (CDNA) $430.91 Million -17.78% 0.26x $1.00 Billion
Check Cap Ltd (CHEK) $13.03 Million -81.27% 0.18x $9.42 Million

About Precipio Inc

NASDAQ:PRPO USA Diagnostics & Research
Market Cap
$50.11 Million
Market Cap Rank
#23541 Global
#4878 in USA
Share Price
$30.94
Change (1 day)
+0.13%
52-Week Range
$6.21 - $31.75
All Time High
$12238.78
About

Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomar… Read more